FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

32965411000001106: Uptravi 1,000microgram tablets (Janssen-Cilag Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Aug 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1389281000001112 Uptravi 1,000microgram tablets (Janssen-Cilag Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1389291000001114 Uptravi 1,000microgram tablets (Janssen-Cilag Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Uptravi 1,000microgram tablets (Janssen-Cilag Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Uptravi 1,000microgram tablets (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Uptravi 1,000microgram tablets (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Uptravi 1,000microgram tablets (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Uptravi 1,000microgram tablets (Janssen-Cilag Ltd) Is a Selexipag 1mg tablets true Inferred relationship Existential restriction modifier
Uptravi 1,000microgram tablets (Janssen-Cilag Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Uptravi 1,000microgram tablets (Janssen-Cilag Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Uptravi 1,000microgram tablets (Janssen-Cilag Ltd) Has specific active ingredient Selexipag false Inferred relationship Existential restriction modifier
Uptravi 1,000microgram tablets (Janssen-Cilag Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Uptravi 1,000microgram tablets (Janssen-Cilag Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Uptravi 1,000microgram tablets (Janssen-Cilag Ltd) Is a Uptravi true Inferred relationship Existential restriction modifier
Uptravi 1,000microgram tablets (Janssen-Cilag Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Uptravi 1,000microgram tablets (Janssen-Cilag Ltd) Has active ingredient Vasodilator false Inferred relationship Existential restriction modifier
Uptravi 1,000microgram tablets (Janssen-Cilag Ltd) Has specific active ingredient Selexipag true Inferred relationship Existential restriction modifier
Uptravi 1,000microgram tablets (Janssen-Cilag Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Uptravi 1,000microgram tablets (Janssen-Cilag Ltd) 60 tablet Has AMP True Uptravi 1,000microgram tablets (Janssen-Cilag Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start